Evolve Private Wealth LLC Sells 4,343 Shares of Accenture PLC $ACN
π Evolve Private Wealth LLC reduced its Accenture holdings by 64.2% in Q1, selling 4,343 shares to retain a $481,000 position.
π Multiple institutional investors including Triumph Capital Management and the Board of the Pension Protection Fund initiated new stakes valued at approximately $27,000 each in Q4.
πΌ CEO Atsushi Egawa sold 4,872 shares for $863,026 under a pre-arranged trading plan, reducing his personal position by 27.57%.
π Analyst consensus rating is 'Hold' with an average price target of $195.00, reflecting divergent views among major banks.
π° Wells Fargo and Wolfe Research maintain bullish 'overweight' or 'outperform' ratings with $200 price objectives for the stock.
π Susquehanna lowered its price objective to $140 with a 'neutral' rating, while BMO Capital Markets set a target of $150.
π Accenture beat quarterly earnings estimates, reporting $3.80 EPS compared to the consensus expectation of $3.70.
π΅ Revenue for the quarter reached $18.72 billion, representing a 5.6% increase year-over-year despite missing analyst revenue expectations.
π The company initiated a new $2.0 billion share buyback program authorized by its Board of Directors on June 23rd.
πΈ A quarterly dividend of $1.63 per share was declared, with an ex-dividend date of July 9th and payment on August 14th.
- Accenture reported earnings per share of $3.80, beating analyst consensus estimates of $3.70 by $0.10.
- The company achieved a net margin of 10.66% and a return on equity of 26.47% for the quarter.
- Revenue grew 5.6% year-over-year to reach $18.72 billion, demonstrating continued business expansion.
- Wells Fargo & Company reiterated an 'overweight' rating with a $200.00 price objective.
- Wolfe Research reaffirmed an 'outperform' rating and set a $200.00 price target.
- The Board of Directors authorized a new $2.0 billion share buyback program, signaling confidence in the stock's value.
- A quarterly dividend of $1.63 per share was declared, offering a 5.1% dividend yield to shareholders.
- JPMorgan Chase & Co. cut its price objective on Accenture from $247.00 to $201.00.
- Susquehanna reduced its price objective from $186.00 to $140.00 and downgraded the rating to 'neutral'.
- BMO Capital Markets reissued a 'market perform' rating with a lower $150.00 target price.
- Accenture's revenue of $18.72 billion missed analysts' expectations of $18.78 billion by $60 million.